View in EDS Linked Full Text
Saved in:
Bibliographic Details
Source: CPT: Pharmacometrics & Systems Pharmacology, Vol 11, Iss 8, Pp 1111-1121 (2022)
Publisher Information: Wiley, 2022.
Publication Year: 2022
Subject Terms: Therapeutics. Pharmacology, RM1-950
Description:
Abstract Rivaroxaban is approved in various regions for the treatment of acute venous thromboembolism (VTE) in children aged between 0 and 1
Database: Directory of Open Access Journals